Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11513 - 11520 of 12008 results
Opposition Heats Up to ICANN's New gTLD Program
November 21, 2011| Blog| Viewpoint
Texas Federal Judge Finding Does Not Add Much to Privacy Debate Over Location Data
November 21, 2011| Blog| Viewpoint
Use the UDRP to Reclaim That Trademarked Domain Name? Maybe Not.
November 16, 2011| Blog| Viewpoint
OIG Approves Arrangement Based on New Exception to Beneficiary Inducement Prohibition
November 16, 2011| Blog| Viewpoint
Section 1(b) Intent-To-Use Applications: Evidence of Bona Fide Intent Required
November 15, 2011| Blog| Viewpoint
Psychiatric Disabilities Under the ADA: proposed changes to diagnostic tool may result in a broader definition of "disability"
November 14, 2011| Blog| Viewpoint
Arbitrator, Not Court, Should Determine Whether Employment Agreements Permit Collective Arbitration, Says New York Appellate Court
November 10, 2011| Blog| Viewpoint
Breaking News -- Wall Street Journal: Facebook Close to Settlement with the Federal Trade Commission
November 10, 2011| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|